Loading viewer...
investor_presentation
Format: PDF investor_presentation
Financial presentation to accompany management commentary FY25 Q2
Financial presentation
to accompany management commentary
The following guidance reflects the Company’s
expectations for the third quarter and fiscal
year 2025 and is provided on a non-GAAP
basis as the Company cannot predict certain
elements that are included in reported GAAP
results, such as the changes in fair value of the
Company’s equity and other investments.
Growth rates reflect an adjusted basis for prior
year results. Third Quarter
The Company’s fiscal third quarter guidance is based on the following FY24 Q3 figures: Net Sales: $159.4 billion,
operating income: $6.2 billion, and adjusted EPS1: $0.51. Guidance contemplates the impact of timing of festive
events in the Company’s international segment and the timing of planned expenses.
Consolidated net sales (cc) Increase 3.25% to 4.25%
Consolidated operating income (cc) Increase 3.0% to 4.5%
Adjusted EPS $0.51 to $0.52
The Company’s fiscal year guidance is based on the following FY24 figures: Net sales: $642.6 billion, adjusted
operating income1: $27.1 billion, and adjusted EPS1: $2.22. The Company’s full year guidance assumes a generally
stable consumer and continued pressure from its mix of products and formats globally.
Metric FY 2025 (updated) FY 2025 (original)
Consolidated net sales (cc) Increase 3.75% to 4.75% Increase 3.0% to 4.0%
Consolidated adj. operating income (cc) Increase 6.5% to 8.0% Increase 4.0% to 6.0%
Interest, net Increase approximately $100M Increase approximately $100M to $200M
Effective tax rate Lower-end of original guidance Approximately 25.0% to 26.0%
Non-controlling interest Unchanged from original guidance Relatively flat
Adjusted EPS $2.35 to $2.43 $2.23 to $2.37
Capital expenditures Unchanged from original guidance Approximately 3.0% to 3.5% of net sales
1For relevant reconciliations, see Q3 FY24 and Q4 FY24 earnings releases furnished on Form 8-K on November 16, 2023 and February 20, 2024, respectively. Per share
amounts have been retroactively adjusted to reflect the February 23, 2024 stock split.
Preview truncated — download the full document for the complete content.
Yelp
Teva Pharmaceutical Industries Investor Presentation — February 2022
investor_presentationinvestor_presentation
50 Pages
Teva Pharmaceutical Industries
Keppel Pacific Oak US REIT 2023 Bangkok Roadshow
investor_presentationinvestor_presentation
31 Pages
Keppel Pacific Oak US REIT
Independent Bank Group IBTX Merger 2016
investor_presentationinvestor_presentation
19 Pages
Independent Bank Group, Inc.